Calamos Advisors LLC Has $76.88 Million Stock Position in Intuitive Surgical, Inc. $ISRG

Key Points

• Calamos Advisors LLC increased its stake in Intuitive Surgical by 20% in Q4 to 135,737 shares, a position valued at about $76.88 million.
• Intuitive Surgical reported a strong Q1 (EPS $2.50 vs. $2.08 consensus; revenue $2.77B, +23% YoY), prompting bullish analyst actions and a consensus target price of $581.91.
• Offsetting risks include instrument recalls, creeping competition (e.g., J&J), mixed analyst revisions, and notable insider selling (32,943 shares, ~$17.28M over 90 days) that could increase near‑term volatility.

Calamos Advisors LLC boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 20.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 135,737 shares of the medical equipment provider's stock after purchasing an additional 22,597 shares during the quarter. Calamos Advisors LLC's holdings in Intuitive Surgical were worth $76,876,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently modified their holdings of the company. Holos Integrated Wealth LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter worth approximately $25,000. Newbridge Financial Services Group Inc. boosted its stake in Intuitive Surgical by 300.0% in the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider's stock valued at $25,000 after acquiring an additional 33 shares during the last quarter. Greykasell Wealth Strategies Inc. bought a new position in Intuitive Surgical in the third quarter valued at approximately $27,000. Olistico Wealth LLC acquired a new stake in Intuitive Surgical during the 4th quarter worth $28,000. Finally, Caitlin John LLC acquired a new stake in Intuitive Surgical during the 3rd quarter worth $30,000. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $482.22 on Friday. Intuitive Surgical, Inc. has a twelve month low of $427.84 and a twelve month high of $603.88. The firm's 50 day moving average price is $477.47 and its two-hundred day moving average price is $515.38. The firm has a market cap of $170.78 billion, a P/E ratio of 58.45, a PEG ratio of 4.09 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The company had revenue of $2.77 billion during the quarter, compared to analysts' expectations of $2.62 billion. During the same quarter in the prior year, the company earned $1.81 earnings per share. The business's quarterly revenue was up 23.0% compared to the same quarter last year. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 8.2 earnings per share for the current fiscal year.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Q1 beat and accelerating growth — ISRG reported a better-than-expected Q1 (EPS $2.50 vs. $2.08 consensus) with ~23% revenue growth and commentary pointing to rising procedures and an improved outlook, which underpins the stock's upside today. Intuitive Surgical Beats Q1 — TipRanks
• Positive Sentiment: Innovation and pricing power — Coverage notes revenue is outpacing procedures as the da Vinci 5 platform drives higher ASPs and service/consumable mix, supporting margin and longer-term upside. Innovation-Led Growth — Zacks
• Positive Sentiment: Analyst support — Several sell‑side actions are favorable: Robert W. Baird raised its price target to $610 and BTIG reaffirmed a Buy; Goldman published a bullish outlook, adding conviction to the post‑earnings rally. Baird Raises PT — AmericanBankingNews BTIG Reaffirms Buy — AmericanBankingNews
• Neutral Sentiment: Mixed analyst moves — Some firms trimmed targets (Jefferies to $515, Leerink and others adjusted targets), leaving consensus views varied; this increases volatility around near‑term price action. Jefferies Lowers PT — AmericanBankingNews
• Neutral Sentiment: Short interest signal is uninformative — April data reported no meaningful short interest (0 shares reported), so short-squeeze risk appears minimal based on the published figures.
• Neutral Sentiment: Contained cyber incident disclosed — Management reported a contained cyber event with remediation underway; investors will watch disclosures but the company says operations are not materially disrupted. Cybersecurity and Q1 Coverage — Yahoo
• Negative Sentiment: Instrument recalls raise reliability questions — ISRG initiated multiple recalls of reusable da Vinci instruments after safety complaints (fraying/broken cables); recalls could pressure service/consumables revenue and hospital confidence if issues persist. Recalls and Revenue Risk — Yahoo
• Negative Sentiment: Competition creeping in — Johnson & Johnson earned CE mark for a stapler that integrates with Ottava, signaling incremental competition in the surgical robotics ecosystem that investors should monitor. J&J CE Mark — MedTechDive

Analyst Ratings Changes

ISRG has been the subject of a number of recent analyst reports. Leerink Partners dropped their price objective on Intuitive Surgical from $622.00 to $573.00 and set an "outperform" rating for the company in a report on Wednesday. Truist Financial decreased their target price on Intuitive Surgical from $650.00 to $580.00 and set a "buy" rating for the company in a research report on Wednesday, April 15th. Wall Street Zen cut Intuitive Surgical from a "buy" rating to a "hold" rating in a research note on Saturday, February 7th. The Goldman Sachs Group increased their price target on shares of Intuitive Surgical from $609.00 to $621.00 and gave the company a "buy" rating in a research report on Wednesday. Finally, Barclays set a $651.00 price objective on shares of Intuitive Surgical and gave the stock an "overweight" rating in a research note on Thursday. Eighteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $581.91.

Insider Activity at Intuitive Surgical

In other news, VP Fredrik Widman sold 133 shares of the business's stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $65,829.68. Following the sale, the vice president owned 660 shares of the company's stock, valued at $326,673.60. The trade was a 16.77% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Mark Brosius sold 2,362 shares of the business's stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $498.68, for a total transaction of $1,177,882.16. Following the sale, the senior vice president directly owned 3,554 shares in the company, valued at $1,772,308.72. This trade represents a 39.93% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 32,943 shares of company stock valued at $17,279,568 over the last ninety days. Company insiders own 0.60% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.